Tryptamine Therapeutics Health Care
Biotech Canada Healthcare North America Pharmaceuticals

$TBC

High $0.03	Low $0.03	Trades -	Turnover $0	Volume 1,701,725
24 July 2026 at 8:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code TYP	Name Tryptamine Therapeutics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 1,609,510,143	Shares Floated 941,889,916	Held by Insiders 34.595%	Held by Institutions 5.387%

Directors & Officers

Name & Education	Position
Mr. Jason Alan Carroll	MD, CEO & Executive Director
Dr. James P. Gilligan MSIB, Ph.D.	President & Chief Scientific Officer
Mr. Christopher Leo Ntoumenopoulos	Executive Director
Mr. Hamish George B.Com., C.A.	CFO & Company Secretary
Dr. Michael H. Silverman B.Sc., F.A.C.P., FACR, M.B.A., M.D.	Chief Medical Officer

TYP Historic Dividends

Date	Amount
We found no dividends on record for TYP.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.03	2,158,274	0.00 (0.00%)
12-Sep	$0.03	1,701,725	0.00 (0.00%)
11-Sep	$0.03	2,085,328	0.00 (5.88%)
05-Sep	$0.03	2,057,902	+0.00 (6.25%)
04-Sep	$0.03	1,567,195	0.00 (3.03%)
03-Sep	$0.03	3,727,976	0.00 (2.94%)
29-Aug	$0.03	2,135,553	+0.00 (6.25%)
28-Aug	$0.03	3,085,059	0.00 (3.03%)
22-Aug	$0.03	1,777,229	0.00 (2.94%)
21-Aug	$0.03	405,692	0.00 (2.86%)
15-Aug	$0.04	2,203,203	0.00 (0.00%)
14-Aug	$0.04	143,164	+0.00 (6.06%)
07-Aug	$0.03	2,072,126	+0.00 (3.13%)
31-Jul	$0.03	5,717,677	0.00 (0.00%)
30-Jul	$0.03	232,054	+0.00 (3.23%)
5 up, 6 down, and 4 flat days

Market Cap (19-Sep) $47,517,424	EBITDA -	PE 0.00	Book Value $0.00
Dividend per Share N/A	Dividend Yield N/A	EPS $0.00	Profit Margin N/A
Operating Margin -74.6%	ROA 45.59%	ROE 92.07%	Revenue (FY) $1,581,674
Revenue per Share $0.00	Gross Profit (FY) $-816,894	Q' YOY Revenue Growth -	Q' YOY Earnings Growth -

Tryptamine Therapeutics Health Care
Biotech Canada Healthcare North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2023)

Directors & Officers

TYP Historic Dividends

Followers

Prices

Announcements

End of Day Prices

TYP Tryptamine Therapeutics Health Care Biotech Canada Healthcare North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2023)

Directors & Officers

TYP Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Tryptamine Therapeutics Health Care
Biotech Canada Healthcare North America Pharmaceuticals